Genicular Nerve Block for Pain Management in Patients With Knee Osteoarthritis: A Randomized Placebo-Controlled Trial

被引:9
|
作者
Shanahan, Ernst M. [1 ,2 ]
Robinson, Lucinda [2 ]
Lyne, Suellen [2 ]
Woodman, Richard [1 ]
Cai, Fin [2 ]
Dissanayake, Kokum [2 ]
Paddick, Kate [3 ]
Cheung, Giovanna [3 ]
Voyvodic, Frank [3 ,4 ]
机构
[1] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia
[2] Flinders Med Ctr, Dept Rheumatol, Adelaide, SA, Australia
[3] Flinders Med Ctr, Dept Radiol, Adelaide, SA, Australia
[4] Bensons Radiol, Adelaide, SA, Australia
关键词
VISUAL ANALOG SCALE; CLINICAL-TRIALS; DOUBLE-BLIND; RADIOFREQUENCY; SEVERITY; HIP;
D O I
10.1002/art.42384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study was undertaken to determine the efficacy of ultrasound-guided genicular nerve block (GNB) for the management of knee pain in patients with knee osteoarthritis. Methods We performed a 12-week parallel-group, placebo-controlled randomized trial of GNB. Within 2 weeks of randomization, patients with knee osteoarthritis in the active arm received 3 injections of 5.7 mg celestone chronodose (1 ml) and 0.5% bupivacaine (3 ml) to the inferomedial, superomedial, and superolateral genicular nerves; patients with knee osteoarthritis in the placebo arm received injections of normal saline. At baseline and at weeks 2, 4, 8, and 12, patients recorded their pain and disability on a 100-mm visual analog scale (VAS) (the primary outcome measure), the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC), and the Intermittent and Constant Osteoarthritis Pain scale. Statistical significance was set at a 2-sided Type I error of alpha = 0.0125 for comparisons at each of the 4 time points. We used a global perceived effect scale to measure patient satisfaction. Results The 59 patients (36 female, 23 male) who completed the trial had a mean +/- SD age of 68.2 +/- 8.6 years. Patients in the active group reported improvements in pain scores at 2, 4, 8, and 12 weeks with a diminution of the effect over time. VAS scores at baseline and at weeks 2, 4, 8, and 12 in the active group (n = 31) versus placebo group (n = 28) were 6.2 versus 5.3 (P = 0.294), 2.7 versus 4.7 (P < 0.001), 3.2 versus 5.1 (P < 0.001), 3.9 versus 4.9 (P < 0.001), and 4.6 versus 5.1 (P = 0.055), respectively. Total WOMAC scores at baseline and at weeks 2, 4, 6, 8, and 12 in the active group versus the placebo group were 54.5 versus 48.1 (P = 0.177), 32.9 versus 44.4 (P < 0.001), 33.7 versus 45.8 (P < 0.001), 39.2 versus 44.8 (P = 0.001), and 42.65 versus 45.1 (P = 0.012), respectively. Conclusion GNB offers short-term pain relief for knee osteoarthritis.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 50 条
  • [1] GENICULAR NERVE BLOCK FOR PAIN MANAGEMENT IN PATIENTS WITH KNEE OSTEOARTHRITIS: A RANDOMISED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Shanahan, Michael
    Cai, Fin
    Voyvodic, Frank
    Woodman, Richard
    Lyne, Suellen
    Dissanayake, Kokum
    Paddick, Kate
    Cheung, Giovanna
    Robinson, Lucinda
    [J]. INTERNAL MEDICINE JOURNAL, 2022, 52 : 29 - 29
  • [2] Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis: A Randomised Double-blind Placebo Controlled Trial
    Shanahan, Ernst
    Cai, Fin
    Voyvodic, Frank
    Lyne, Suellen
    Woodman, Richard
    Dissanayake, Kokum
    Paddick, Kate
    Cheung, Giovanna
    Robinson, Lucinda
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3741 - 3742
  • [3] THERAPEUTIC GENICULAR NERVE BLOCK FOR CHRONIC PAIN MANAGEMENT IN PATIENTS WITH KNEE OSTEOARTHRITIS
    Karbic, Vlasta Orlic
    Sustic, Alan
    [J]. ACTA CLINICA CROATICA, 2023, 62 : 34 - 39
  • [4] Analgesic effectiveness of methoxyflurane inhaler during genicular nerve block in knee osteoarthritis: a randomized controlled trial
    Sawang, Saowanee
    Kimpee, Pretimon
    Itthichaikulthol, Wichai
    Tontisirin, Nuj
    Limpoon, Suwimon
    Seangrung, Rattaphol
    Pasutharnchat, Koravee
    Cohen, Steven Paul
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2024,
  • [5] An infrapatellar nerve block reduces knee pain in patients with chronic anterior knee pain after tibial nailing: a randomized, placebo-controlled trial in 34 patients
    Leliveld, Mandela S.
    Kamphuis, Saskia J. M.
    Verhofstad, Michael H. J.
    [J]. ACTA ORTHOPAEDICA, 2019, 90 (04) : 377 - 382
  • [6] An infrapatellar nerve block reduces knee pain in patients with chronic anterior knee pain after tibial nailing: a randomized, placebo-controlled trial in 34 patients
    Leliveld, Mandala S.
    Kamphuis, Saskia J. M.
    Verhofstad, Michael H. J.
    [J]. ACTA ORTHOPAEDICA, 2019, 90 (05) : 505 - 506
  • [7] Genicular Nerve Block for Knee Osteoarthritis
    Vilchez-Cavazos, Felix
    Alonso, Augusto A. Gamboa
    Simental-Mendia, Mario
    Pena-Martinez, Victor M.
    Acosta-Olivo, Carlos A.
    Villarreal-Villarreal, Gregorio A.
    [J]. CLINICAL JOURNAL OF PAIN, 2024, 40 (10): : 618 - 624
  • [8] Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial
    Abou-Raya, Suzan
    Abou-Raya, Anna
    Helmii, Madihah
    [J]. AGE AND AGEING, 2012, 41 (05) : 646 - 652
  • [9] A RANDOMIZED PLACEBO-CONTROLLED TRIAL OF ORAL RESVERATROL FOR PATIENTS WITH PAINFUL KNEE OSTEOARTHRITIS (ARTHROL)
    Nguyen, Christelle
    Coudeyre, Emmanuel
    Sellam, Jeremie
    Berenbaum, Francis
    Rannou, Francois
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S51 - S51
  • [10] Osteoarthritis of the Knee, Inflammation, and the Effect of Adalimumab: A Randomized Placebo-Controlled Trial
    Maksymowych, Walter P.
    Bessette, Louis
    Lambert, Robert G.
    Carapellucci, Amanda
    Appleton, Tom
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3738 - 3740